Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico

We report a 39-year-old male with an aneurysmal subarachnoid hemorrhage without hydrocephalus, in whom a right choroidal aneurysm was early excluded by endovascular coil insertion. Intracranial pressure (PIC) and cerebral oxygenation (PtiO2) sensors for neuromonitoring were installed due to a persis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Regueira,Tomás, Reccius,Andrés, Ducci,Héctor, Torres,Fabián, Soto,Leonardo, Cordovez,Jorge, Galvez,Marcelo, Contreras,Luis, Mena,Francisco
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2019
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000901210
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872019000901210
record_format dspace
spelling oai:scielo:S0034-988720190009012102020-01-07Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínicoRegueira,TomásReccius,AndrésDucci,HéctorTorres,FabiánSoto,LeonardoCordovez,JorgeGalvez,MarceloContreras,LuisMena,Francisco Nimodipine Subarachnoid Hemorrhage Vasospasm, Intracraneal We report a 39-year-old male with an aneurysmal subarachnoid hemorrhage without hydrocephalus, in whom a right choroidal aneurysm was early excluded by endovascular coil insertion. Intracranial pressure (PIC) and cerebral oxygenation (PtiO2) sensors for neuromonitoring were installed due to a persistent comatose state. From the 3rd day, neuromonitoring became altered. CT angiography and cerebral angiography showed severe proximal and distal vasospasm (VE) of the middle (ACM) and anterior (ACA) right cerebral arteries. VE was treated with angioplasty and intravenous nimodipine. Forty eight hours later, despite hemodynamic maximization, neuromonitoring became altered again, mainly explained by a decrease in PtiO2 below 15 mmHg. A severe VE in ACM and right ACA was confirmed by angiography. Given the presence of an early and recurrent VE, which was associated with a decrease in cerebral oxygenation, internal carotid micro-catheters for continuous nimodipine infusion were installed. This therapy maintained a normal neuromonitoring for 15 days. During this period, attempts were done to decrease or discontinue the infusion, but the patient presented parallel falls of cerebral oxygenation or decreased cerebral perfusion observed with perfusion CT, interpreted as persistent VE. Finally, the infusion was stopped at day 15 without significant complication. We conclude that intra-arterial nimodipine continuous infusion in refractory VE can be useful and safe in selected patients. Multimodal neuromonitoring is essential.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.147 n.9 20192019-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000901210es10.4067/s0034-98872019000901210
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Nimodipine
Subarachnoid Hemorrhage
Vasospasm, Intracraneal
spellingShingle Nimodipine
Subarachnoid Hemorrhage
Vasospasm, Intracraneal
Regueira,Tomás
Reccius,Andrés
Ducci,Héctor
Torres,Fabián
Soto,Leonardo
Cordovez,Jorge
Galvez,Marcelo
Contreras,Luis
Mena,Francisco
Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
description We report a 39-year-old male with an aneurysmal subarachnoid hemorrhage without hydrocephalus, in whom a right choroidal aneurysm was early excluded by endovascular coil insertion. Intracranial pressure (PIC) and cerebral oxygenation (PtiO2) sensors for neuromonitoring were installed due to a persistent comatose state. From the 3rd day, neuromonitoring became altered. CT angiography and cerebral angiography showed severe proximal and distal vasospasm (VE) of the middle (ACM) and anterior (ACA) right cerebral arteries. VE was treated with angioplasty and intravenous nimodipine. Forty eight hours later, despite hemodynamic maximization, neuromonitoring became altered again, mainly explained by a decrease in PtiO2 below 15 mmHg. A severe VE in ACM and right ACA was confirmed by angiography. Given the presence of an early and recurrent VE, which was associated with a decrease in cerebral oxygenation, internal carotid micro-catheters for continuous nimodipine infusion were installed. This therapy maintained a normal neuromonitoring for 15 days. During this period, attempts were done to decrease or discontinue the infusion, but the patient presented parallel falls of cerebral oxygenation or decreased cerebral perfusion observed with perfusion CT, interpreted as persistent VE. Finally, the infusion was stopped at day 15 without significant complication. We conclude that intra-arterial nimodipine continuous infusion in refractory VE can be useful and safe in selected patients. Multimodal neuromonitoring is essential.
author Regueira,Tomás
Reccius,Andrés
Ducci,Héctor
Torres,Fabián
Soto,Leonardo
Cordovez,Jorge
Galvez,Marcelo
Contreras,Luis
Mena,Francisco
author_facet Regueira,Tomás
Reccius,Andrés
Ducci,Héctor
Torres,Fabián
Soto,Leonardo
Cordovez,Jorge
Galvez,Marcelo
Contreras,Luis
Mena,Francisco
author_sort Regueira,Tomás
title Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
title_short Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
title_full Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
title_fullStr Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
title_full_unstemmed Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
title_sort terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. caso clínico
publisher Sociedad Médica de Santiago
publishDate 2019
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872019000901210
work_keys_str_mv AT regueiratomas terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT recciusandres terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT duccihector terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT torresfabian terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT sotoleonardo terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT cordovezjorge terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT galvezmarcelo terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT contrerasluis terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
AT menafrancisco terapiacontinuaintraarterialselectivaconnimodipinoparaeltratamientodelvasoespasmorefractarioenhemorragiasubaracnoideaaneurismaticacasoclinico
_version_ 1718437084780298240